期刊文献+

高血压病患者不同左心室几何构型血浆心肌营养素-1水平的变化 被引量:1

Relationship between plasma cardiotrophin 1 and left ventricular geometry in patients with essential hypertension
原文传递
导出
摘要 目的探讨高血压病患者不同左心室几何构型与血浆心肌营养素-1(CT-1)水平的关系。方法对80例血压达标的高血压病患者进行超声心动图检查,依据左心室质量指数(LVMI)、左心室相对室壁厚度将患者分为左心室正常构型组(n=20)、向心性重构组(n=22)、向心性肥厚组(n=20)和离心性肥厚组(n=18)。健康体检者为对照。ELISA法测定血浆CT-1水平。结果所有高血压病患者血浆CT-1水平显著高于对照组(P<0.01)。血浆CT-1水平:左心室向心性重构组显著高于正常构型组(P=0.004)、向心性肥厚组显著高于向心性重构组(P=0.049)、离心性肥厚组显著高于向心性肥厚组(P=0.001)。左心室向心性肥厚组(r=0.626,P=0.009)、离心性肥厚组(r=0.573,P=0.017)患者的血浆CT-1水平与LVMI显著正相关。结论对于血压控制达标的高血压病患者,血浆CT-1水平仍可以很好地反映左心室质量的严重程度。 Objective To investigate the relationship between the levels of plasma eardiotrophin I(CT-1) and left ventricular geometry in patients with essential hypertension. Methods 80 essential hypertension patients who achieved successful blood pressure control were studied with eehocardiographie examination. According to left ventricular mass index (LVMI) and relative wall thickness (RWT), the patients were divided into left ventricular normal geometry group (n=20), concentric remodeling group (nffi22), concentric hypertrophy group (nffi20) and eccentric hypertrophy group (n=18): 20 healthy subjects were enrolled as control. The levels of plasma CT-1 were measured by enzyme linked immunosorbent assay (ELISA). Results The levels of plasma CT-1 were higher in all the patients with essential hypertension than in the healthy controls (P〈0.01). Compared with the normal geometry group, plasma CT-1 levels were higher in the concentric remodeling group[(94.50±25.67)pg/ml vs. (69.60±14.94) pg/ml, P=0.004]. The levels of plasma CT-1 were higher in the concentric hypertrophy group[(117.45±24.34) pg/ml] than in the concentric remodeling group (P=-0.049), but lower than in the eccentric hypertrophy group[(171.78±42.77)pg/ml, P=0.001]. There was a significant positive correlation between the levels of plasma CT-1 and LVMI (P〈0.05) in patients with left ventrieular hypertrophy(LVH). Conclusion Plasma CT-1 has discriminative value in identifying the presence of LVH even in essential hypertension patients achieving successful blood pressure control.
出处 《中华临床医师杂志(电子版)》 CAS 2015年第10期33-37,共5页 Chinese Journal of Clinicians(Electronic Edition)
关键词 高血压 肥大 左心室 心肌营养素-1 Hypertension Hypertrophy, left ventricular Cardiotrophin 1
  • 相关文献

参考文献20

  • 1冯宇,莫绪明.心肌营养素-1在心血管系统中作用的研究进展[J/CD].中华临床医师杂志:电子版,2012,6(20):6473-6475.
  • 2González A,López B,Ravassa S,et al.Cardiotrophin-1 in hypertensive heart disease[J].Endocrine,2012,42(1):9-17.
  • 3Schillaci G,Pucci G,Perlini S.From hypertension to hypertrophy to heart failure:the role of cardiotrophin-1[J].J Hypertens,2013,31(3):474-476.
  • 4中国高血压防治指南2010[J].中华心血管病杂志,2011,39(7):579-616. 被引量:4555
  • 5Devereux RB,Alonso DR,Lutas EM,et al.Echocardiagraphic assessment of left ventricular hypertrophy:comparison to necropsy findings[J].Am J Cardiol,1986,57(6):450-458.
  • 6Ganau A,Devereux RB,Roman MJ,et al.Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension[J].J Am Coll Cardiol,1992,19(7):1550-1558.
  • 7Yingxin P,Jiang S,Xiaoyong Q,et al.Regulation of the catecholamineβ-adrenergic system in ventricular remodeling of hypertension[J].Jpn Heart J,2004,45(2):285-296.
  • 8Jougasaki M.Cardiotrophin-1 in cardiovascular regulation[J].Adv Clin Chem,2010,52:41-76.
  • 9Pemberton CJ,Raudsepp SD,Yandle TG,et al.Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch[J].Cardiovasc Res,2005,68(1):109-117.
  • 10López B,González A,Lasarte JJ,et al.Is plasma cardiotrophin-1 a marker of hypertensive heart disease?[J].J Hypertens,2005,23(3):625-632.

共引文献4554

同被引文献33

  • 1王祖禄,佟铭,刘振春,陈新,杨再强.磁共振成像对高血压性心脏病左心室肥厚的诊断价值[J].中国高血压杂志,1993,1(1):24-26. 被引量:4
  • 2Maskey A, Parajuli M, Kohli SC. A study of risk factors of stroke in patients admitted in Manipal Teaching Hospital, Pokhara[J]. Kathmandu Univ Med J (KUMJ) ,2011,9(36) :244-247.
  • 3Jain A, Tandri H, Dalal D, et al. Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the multi- ethnic study of atherosclerosis (MESA) [J]. Am Heart J, 2010,159 (4) :652- 658.
  • 4Pewsner D, Juni P, Egger M, et al. Accuracy of electroeardio graphy in diagnosis of left ventricular hypertrophy in arterial hy- pertension = systematic review[J]. BMJ, 2007,335 ( 7622) : 711.
  • 5Hawkins NM, Wang D, McMurray JJ, et al. Prevalence and prognostic implications of electrocardiographic left ventricular hy- pertrophy in heart failure= evidence from the CHARM programme[J]. Heart, 2007,93(1) :59-64.
  • 6Maunganidze F, Woodiwiss AJ, Libhaber CD, et al. Left ventric- ular hypertrophy detection from simple clinical measures combined with electrocardiographic criteria in a group of African ancestry[J]. Clin Res Cardiol,2014,103(11):921- 929.
  • 7Faliaredondo FJ, Ferndndez-Bergas D, Calderan A, et al. Preva- lence of left-ventricular hypertrophy by multiple electrocardio- graphic criteria in general population: Hermex study[J]. J Hyper- tens,2012,30(7) : 1460-1467.
  • 8Angeli F, Verdecchia P, Iacobellis G, et al. Usefulness of QRS voltage correction by body mass index to improve electrocardio- graphic detection of left ventricular hypertrophy in patients with systemic hypertension[J]. Am J Cardiol,2014,114(3) :427-432.
  • 9Wachtell K, Bella JN, Liebson PR, et al. Impact of different par- tition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study[J]. Hypertension, 2000,35(1 Pt 1) :6- 12.
  • 10Devereux RB, Palmieri V, Liu JE, et al. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the losartan intervention for endpoint reduction study[J]. J Hyper- tens, 2002,20(7) :1445-1450.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部